ctrl K

Kinnate Biopharma Inc. (KNTE)

NASDAQ: KNTE · Real-Time Price · USD

2.65

-0.01 (-0.38%)

At close: Apr 02, 2024, 8:00 PM

Kinnate Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	57M	29.26M	116.1M	365.46M	76.45M	7M
Short-Term Investments	97.04M	172.21M	103.36M	31.4M	n/a	n/a
Long-Term Investments	10.63M	39.14M	105.45M	n/a	n/a	n/a
Other Long-Term Assets	38K	2.4M	1.77M	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	973K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.14M	3.64M	5.64M	3.34M	25K	n/a
Total Current Assets	158.18M	230.84M	258.69M	400.2M	77.45M	8.08M
Property-Plant & Equipment	4.76M	6.45M	956K	368K	154K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	15.43M	47.99M	108.17M	368K	154K	n/a
Total Assets	173.6M	278.83M	366.86M	400.57M	77.61M	8.08M
Account Payables	2.03M	2.97M	3.15M	3.94M	956K	442K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	892K	991K	n/a	n/a	n/a	n/a
Other Current Liabilities	9.07M	13.21M	9.24M	3.36M	989K	25K
Total Current Liabilities	11.99M	17.17M	12.39M	7.3M	1.95M	467K
Long-Term Debt	2.28M	3.19M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.28M	3.19M	35M	n/a	93.15M	n/a
Total Liabilities	14.28M	20.36M	12.39M	7.3M	95.09M	467K
Total Debt	3.17M	4.18M	n/a	n/a	n/a	n/a
Common Stock	5K	4K	4K	4K	n/a	n/a
Retained Earnings	-372.01M	-259.36M	-143.09M	-53.33M	-17.57M	-7.63M
Comprehensive Income	-12K	-1.41M	-524K	-9K	n/a	n/a
Shareholders Equity	159.33M	223.47M	319.48M	393.27M	-17.49M	7.61M
Total Investments	107.67M	211.35M	208.81M	31.4M	n/a	n/a